Mouse Anti-FOSB Recombinant Antibody (CBXF-2350) (V2LY-0925-LY2711)

Tsuda, Y., Suurmeijer, A. J., Sung, Y. S., Zhang, L., Healey, J. H., & Antonescu, C. R. (2021). Epithelioid hemangioma of bone harboring FOS and FOSB gene rearrangements: a clinicopathologic and molecular study. Genes, Chromosomes and Cancer, 60(1), 17-25.

Bridge, J. A., Sumegi, J., Royce, T., Baker, M., & Linos, K. (2021). A novel CLTC‐FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone. Genes, Chromosomes and Cancer, 60(1), 38-42.

Zhang, R., Li, X., Liu, Z., Wang, Y., Zhang, H., & Xu, H. (2020). EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress. Cancer Cell International, 20(1), 1-11.

Zhu, G., Benayed, R., Ho, C., Mullaney, K., Sukhadia, P., Rios, K., ... & Hameed, M. R. (2019). Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Modern Pathology, 32(5), 609-620.

Panagopoulos, I., Lobmaier, I., Gorunova, L., & Heim, S. (2019). Fusion of the genes WWTR1 and FOSB in pseudomyogenic hemangioendothelioma. Cancer Genomics & Proteomics, 16(4), 293-298.

Park, J. A., Na, H. H., Jin, H. O., & Kim, K. C. (2019). Increased expression of fosb through reactive oxygen species accumulation functions as pro-apoptotic protein in Piperlongumine Treated MCF7 breast cancer cells. Molecules and cells, 42(12), 884.

Gajewski, P. A., Eagle, A. L., Williams, E. S., Manning, C. E., Lynch, H., McCornack, C., ... & Robison, A. J. (2019). Epigenetic regulation of hippocampal fosb expression controls behavioral responses to cocaine. Journal of Neuroscience, 39(42), 8305-8314.

Agaram, N. P., Zhang, L., Cotzia, P., & Antonescu, C. R. (2018). Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions. The American journal of surgical pathology, 42(12), 1653.

Hamilton, P. J., Burek, D. J., Lombroso, S. I., Neve, R. L., Robison, A. J., Nestler, E. J., & Heller, E. A. (2018). Cell-type-specific epigenetic editing at the Fosb gene controls susceptibility to social defeat stress. Neuropsychopharmacology, 43(2), 272-284.

Fittall, M. W., Mifsud, W., Pillay, N., Ye, H., Strobl, A. C., Verfaillie, A., ... & Behjati, S. (2018). Recurrent rearrangements of FOS and FOSB define osteoblastoma. Nature communications, 9(1), 2150.

Liu, S., Luan, J., & Ding, Y. (2018). miR-144-3p targets FosB proto-oncogene, AP-1 transcription factor subunit (FOSB) to suppress proliferation, migration, and invasion of PANC-1 pancreatic cancer cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 26(5), 683-690.

Ortins‐Pina, A., Llamas‐Velasco, M., Turpin, S., Soares‐de‐Almeida, L., Filipe, P., & Kutzner, H. (2018). FOSB immunoreactivity in endothelia of epithelioid hemangioma (angiolymphoid hyperplasia with eosinophilia). Journal of Cutaneous Pathology, 45(6), 395-402.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols